| Krishna Hanson, ARNP | |
|
2420 4th St Sw, Mason City, IA 50401-4664 | |
| (641) 450-1637 | |
| (641) 505-1071 |
| Full Name | Krishna Hanson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 2420 4th St Sw, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235894122 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A165764 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Iowa Specialty Hospital - Belmond | Belmond, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iowa Dermatology Clinic Plc | 2961394713 | 20 |
News Archive
Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
Making people fear the coronavirus may motivate us to wash our hands, keep our distance and wear a face mask. But fear also takes a heavy toll on our mental health and is fertile ground for discrimination and prejudice.
Neurodegenerative diseases represent one of the greatest challenges of our aging society. However, investigation into these diseases is made particularly difficult due to the limited availability of human brain tissue. Scientists from the Life & Brain Research Center and Neurology Clinic of Bonn University have now taken a roundabout path: They reprogrammed skin cells from patients with a hereditary movement disorder into so-called induced pluripotent stem cells (iPS cells) and obtained functional nerve cells from them.
The Food and Drug Administration (FDA) today announced the addition of new risk information to the health professional labeling for Zelnorm (tegaserod maleate). Zelnorm is a prescription medication for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.
Senate Majority Leader Harry Reid (D-Nev.) has said that he will attempt to bring legislation that would reauthorize the President's Emergency Plan for AIDS Relief to the Senate floor on Wednesday, CQ Today reports (Graham-Silverman, CQ Today, 6/24).
› Verified 8 days ago
| Entity Name | Iowa Dermatology Clinic Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679687081 PECOS PAC ID: 2961394713 Enrollment ID: O20040326000335 |
News Archive
Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
Making people fear the coronavirus may motivate us to wash our hands, keep our distance and wear a face mask. But fear also takes a heavy toll on our mental health and is fertile ground for discrimination and prejudice.
Neurodegenerative diseases represent one of the greatest challenges of our aging society. However, investigation into these diseases is made particularly difficult due to the limited availability of human brain tissue. Scientists from the Life & Brain Research Center and Neurology Clinic of Bonn University have now taken a roundabout path: They reprogrammed skin cells from patients with a hereditary movement disorder into so-called induced pluripotent stem cells (iPS cells) and obtained functional nerve cells from them.
The Food and Drug Administration (FDA) today announced the addition of new risk information to the health professional labeling for Zelnorm (tegaserod maleate). Zelnorm is a prescription medication for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.
Senate Majority Leader Harry Reid (D-Nev.) has said that he will attempt to bring legislation that would reauthorize the President's Emergency Plan for AIDS Relief to the Senate floor on Wednesday, CQ Today reports (Graham-Silverman, CQ Today, 6/24).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Krishna Hanson, ARNP 2420 4th St Sw, Mason City, IA 50401-4664 Ph: (641) 450-1637 | Krishna Hanson, ARNP 2420 4th St Sw, Mason City, IA 50401-4664 Ph: (641) 450-1637 |
News Archive
Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
Making people fear the coronavirus may motivate us to wash our hands, keep our distance and wear a face mask. But fear also takes a heavy toll on our mental health and is fertile ground for discrimination and prejudice.
Neurodegenerative diseases represent one of the greatest challenges of our aging society. However, investigation into these diseases is made particularly difficult due to the limited availability of human brain tissue. Scientists from the Life & Brain Research Center and Neurology Clinic of Bonn University have now taken a roundabout path: They reprogrammed skin cells from patients with a hereditary movement disorder into so-called induced pluripotent stem cells (iPS cells) and obtained functional nerve cells from them.
The Food and Drug Administration (FDA) today announced the addition of new risk information to the health professional labeling for Zelnorm (tegaserod maleate). Zelnorm is a prescription medication for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.
Senate Majority Leader Harry Reid (D-Nev.) has said that he will attempt to bring legislation that would reauthorize the President's Emergency Plan for AIDS Relief to the Senate floor on Wednesday, CQ Today reports (Graham-Silverman, CQ Today, 6/24).
› Verified 8 days ago
Carrie Potter, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 910 N Eisenhower Ave, Mason City, IA 50401 Phone: 641-428-7000 | |
Victoria Lee Stromer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1631 4th St Sw, Mason City, IA 50401 Phone: 641-428-6000 Fax: 641-428-6007 | |
Ashley Matern, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-6999 Fax: 641-428-6678 | |
Trisha Lynn Tibbitts, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1631 4th St Sw # 114b, Mason City, IA 50401 Phone: 641-243-4593 | |
Alex Scott Farrell, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7234 Fax: 641-428-6373 | |
Tara Eisenlohr, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 1st St Nw Ste 200, Mason City, IA 50401 Phone: 641-423-5044 Fax: 641-423-0994 | |
Brooke Stewart, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1631 4th St Sw, Suite 114b, Mason City, IA 50401 Phone: 641-428-6000 Fax: 641-428-6007 |